Charles Cherington - SEC Form 4 Insider Trading Activity
Summary
Updated Aug 4, 2026
Charles Cherington is a corporate insider tracked by InsiderAlpha. No SEC Form 4 filings recorded in the last 90 days. Lifetime open-market purchases: $2.00M.
Profile
Charles Cherington is a beneficial owner of more than 10% of Ernexa Therapeutics Inc. (ERNA), as disclosed in SEC ownership filings. Cherington has reported 2 insider filings with the SEC since 2024. The most recent filing was in February 2026.
| Role | 10% Owner |
|---|---|
| Notability | 30/100 |
Board memberships
- Ernexa Therapeutics Inc.
Reported roles
- 10% Owner
Trading Pattern
InsiderAlpha's records for Charles Cherington go back to 2024: 2 primary Form 4 filings, an average of 0.7 per year. The typical open-market purchase is $167K (12 buys totaling $2.00M). The largest single buy on record is $2.00M of ERNA in 2026. Sales side: 5 recorded sales totaling , so the filing history runs buy-heavy by dollar value. No transaction on record carries a Rule 10b5-1 flag - the filings look discretionary rather than pre-scheduled, which makes their timing more informative as a signal.
Career & Filing History
Every role Charles Cherington has reported on a Form 4, reconstructed from the filings themselves - reporting insiders must state their relationship to the issuer (officer title, director seat, or 10% ownership) on every filing.
- 10% Owner at Ernexa Therapeutics Inc. (ERNA) - 2 filings, 2024 to 2026
Recent Transactions
| Date | Ticker | Company | Code | Shares | Price | Value |
|---|---|---|---|---|---|---|
| 2026-02-18 | ERNA | Ernexa Therapeutics Inc. | P - Open-market purchase | 4.00M | $0.50 | $2.00M |
| 2024-11-05 | ERNA | Ernexa Therapeutics Inc. | J - Other acquisition / disposition | 2.82M | $0.50 | $1.41M |
| 2024-11-05 | ERNA | Ernexa Therapeutics Inc. | P - Open-market purchase | 1.56M | - | |
| 2024-11-05 | ERNA | Ernexa Therapeutics Inc. | P - Open-market purchase | 5.42M | - | |
| 2024-11-05 | ERNA | Ernexa Therapeutics Inc. | P - Open-market purchase | 1.24M | - | |
| 2024-11-05 | ERNA | Ernexa Therapeutics Inc. | P - Open-market purchase | 4.77M | - | |
| 2024-11-05 | ERNA | Ernexa Therapeutics Inc. | P - Open-market purchase | 261.8K | - |
Most Active Insiders Right Now
Charles Cherington has no recent co-filers at the same companies, so here are the insiders with the largest open-market activity across the market in the last 90 days.
- Magnetar Financial LLC - $8.53B of CRWV open-market activity in the last 90 days
- VisionWave Holdings, Inc. - $7.98B of SVRE open-market activity in the last 90 days
- AI Alpine (Luxembourg) S.a.r.l. - $2.69B of INIO open-market activity in the last 90 days
- SGF FANG Holdings, LP - $2.04B of FANG open-market activity in the last 90 days
- BCP 8 Holdings Mozart Manager L.L.C. - $1.22B of MDLN open-market activity in the last 90 days
- BX Mozart ML-2 Holdco L.P. - $1.22B of MDLN open-market activity in the last 90 days
More Notable Insiders
Other corporate insiders with significant SEC Form 4 track records on InsiderAlpha:
- Dirkson R. Charles
- Jorey Chernett
- John W. Childs
- Mahesh Choudhury
- Jonathan H. Cohen
- Ryan Cohen
- Charles K. Cohn
- Matthew Cohn
Frequently Asked Questions
Who is Charles Cherington?
Charles Cherington is a beneficial owner of more than 10% of Ernexa Therapeutics Inc. (ERNA), as disclosed in SEC ownership filings. Cherington has reported 2 insider filings with the SEC since 2024. The most recent filing was in February 2026.…
Has Charles Cherington been buying or selling stock?
Recorded transactions: 12 open-market purchases ($2.00M) and 5 open-market sales across all tracked filings.
Where can I see all of Charles Cherington's SEC filings?
All Form 4 filings, transaction values, and 10b5-1 plan flags are listed on this page and updated in real time as new SEC EDGAR filings are processed.
Learn More
Open the live Charles Cherington profile on InsiderAlpha for real-time alerts, AI-scored trade ideas, and full transaction history.